Michael Yee Score: 46
Analyst at
UBS
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+11.5%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
69%
37 W / 17 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
74%
26 W / 9 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
26%
9 W / 26 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
17%
6 W / 29 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
65%
20 W / 11 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
66%
33 W / 17 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
100%
4 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jul 23, 2026 |
MBX Biosciences, Inc. Common Stock
MBX
|
BUY |
$90.00
Est. +46%
|
$61.84 | $72.64 |
Pending
|
$67.08
+8.5%
|
| Jun 09, 2026 |
Revolution Medicines Inc
RVMD
|
BUY |
$175.00
Est. +18%
|
$148.45 | $208.76 |
Target Met
|
$202.00
+36.1%
|
| May 27, 2026 |
Pfizer Inc.
PFE
|
BUY |
$27.00
Est. +2%
|
$26.35 | $27.20 |
Bullseye Hit (±1%)
|
$26.80
+1.7%
|
| Mar 06, 2026 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$70.00
Est. +17%
|
$59.79 | $68.10 |
Precision Hit (±3%)
|
$64.65
+8.1%
|
| Feb 24, 2026 |
Arcellx Inc
ACLX
|
BUY |
$115.00
Est. +1%
|
$113.75 | $115.13 |
Bullseye Hit (±1%)
|
$115.07
+1.2%
|
| Jan 08, 2026 |
Ventyx Biosciences Inc
VTYX
|
BUY |
$14.00
Est. +2%
|
$13.73 | $14.07 |
Bullseye Hit (±1%)
|
$14.00
+2.0%
|
| Jan 07, 2026 |
Gilead Sciences, Inc.
GILD
|
BUY |
$145.00
Est. +19%
|
$121.36 | $157.27 |
Target Met
|
$138.14
+13.8%
|
| Jan 07, 2026 |
MBX Biosciences, Inc. Common Stock
MBX
|
BUY |
$60.00
Est. +109%
|
$28.70 | $72.64 |
Target Met
|
$67.08
+133.7%
|
| Jan 07, 2026 |
Olema Pharmaceuticals Inc
OLMA
|
BUY |
$45.00
Est. +80%
|
$25.04 | $29.50 |
Pending
|
$10.51
-58.0%
|
| Jan 07, 2026 |
Oruka Therapeutics, Inc.
ORKA
|
BUY |
$50.00
Est. +88%
|
$26.62 | $109.42 |
Target Met
|
$108.12
+306.2%
|
| Jan 07, 2026 |
Denali Therapeutics Inc
DNLI
|
BUY |
$25.00
Est. +45%
|
$17.21 | $27.30 |
Target Met
|
$24.82
+44.2%
|
| Jan 07, 2026 |
Nuvation Bio Inc - Ordinary Shares - Class A
NUVB
|
BUY |
$10.00
Est. +18%
|
$8.49 | $9.10 |
Pending
|
$6.10
-28.2%
|
| Jan 07, 2026 |
Inventiva - ADR
IVA
|
BUY |
$12.00
Est. +164%
|
$4.54 | $7.29 |
Pending
|
$4.60
+1.3%
|
| Jan 07, 2026 |
Cogent Biosciences Inc
COGT
|
BUY |
$60.00
Est. +73%
|
$34.78 | $43.39 |
Pending
|
$37.31
+7.3%
|
| Jan 07, 2026 |
Immunocore Holdings plc - ADR
IMCR
|
BUY |
$55.00
Est. +67%
|
$32.85 | $36.26 |
Pending
|
$34.20
+4.1%
|
| Jan 07, 2026 |
Schrodinger Inc
SDGR
|
SELL |
$18.00
Est. +4%
|
$18.79 | $10.95 (Low) |
Target Met
|
$18.46
+1.8%
|
| Jan 07, 2026 |
Beam Therapeutics Inc
BEAM
|
SELL |
$28.00
Est. +1%
|
$28.34 | $21.63 (Low) |
Target Met
|
$26.51
+6.5%
|
| Jan 07, 2026 |
SAB Biotherapeutics Inc
SABS
|
BUY |
$7.00
Est. +93%
|
$3.62 | $5.15 |
Pending
|
$3.75
+3.6%
|
| Jan 07, 2026 |
Arcellx Inc
ACLX
|
BUY |
$100.00
Est. +61%
|
$62.06 | $115.13 |
Target Met
|
$115.07
+85.4%
|
| Jan 07, 2026 |
AnaptysBio Inc
ANAB
|
BUY |
$70.00
Est. +59%
|
$43.91 | $72.27 |
Target Met
|
$56.02
+27.6%
|
| Jan 07, 2026 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$60.00
Est. +45%
|
$41.31 | $58.49 |
Precision Hit (±3%)
|
$53.06
+28.4%
|
| Jan 07, 2026 |
Kodiak Sciences Inc
KOD
|
BUY |
$50.00
Est. +100%
|
$25.05 | $47.84 |
Pending
|
$39.98
+59.6%
|
| Jan 07, 2026 |
Aligos Therapeutics Inc
ALGS
|
BUY |
$20.00
Est. +128%
|
$8.76 | $10.49 |
Pending
|
$6.77
-22.7%
|
| Jan 06, 2026 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$535.00
Est. +14%
|
$468.38 | $546.17 |
Precision Hit (±3%)
|
$516.44
+10.3%
|
| Jan 06, 2026 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,250.00
Est. +17%
|
$1,064.04 | $1,249.45 |
Bullseye Hit (±1%)
|
$1,209.85
+13.7%
|
MBX Biosciences, Inc. Common Stock
MBX
Jul 23, 2026
Signal & Target
BUY
$90.00
Start Price
$61.84
Best Price (1Y)
$72.64
Current Price
$67.08
Return
+8.5%
Revolution Medicines Inc
RVMD
Jun 09, 2026
Signal & Target
BUY
$175.00
Start Price
$148.45
Best Price (1Y)
$208.76
Current Price
$202.00
Return
+36.1%
Pfizer Inc.
PFE
May 27, 2026
Signal & Target
BUY
$27.00
Start Price
$26.35
Best Price (1Y)
$27.20
Current Price
$26.80
Return
+1.7%
Bristol-Myers Squibb Co.
BMY
Mar 06, 2026
Signal & Target
BUY
$70.00
Start Price
$59.79
Best Price (1Y)
$68.10
Current Price
$64.65
Return
+8.1%
Arcellx Inc
ACLX
Feb 24, 2026
Signal & Target
BUY
$115.00
Start Price
$113.75
Best Price (1Y)
$115.13
Current Price
$115.07
Return
+1.2%
Ventyx Biosciences Inc
VTYX
Jan 08, 2026
Signal & Target
BUY
$14.00
Start Price
$13.73
Best Price (1Y)
$14.07
Current Price
$14.00
Return
+2.0%
Gilead Sciences, Inc.
GILD
Jan 07, 2026
Signal & Target
BUY
$145.00
Start Price
$121.36
Best Price (1Y)
$157.27
Current Price
$138.14
Return
+13.8%
MBX Biosciences, Inc. Common Stock
MBX
Jan 07, 2026
Signal & Target
BUY
$60.00
Start Price
$28.70
Best Price (1Y)
$72.64
Current Price
$67.08
Return
+133.7%
Olema Pharmaceuticals Inc
OLMA
Jan 07, 2026
Signal & Target
BUY
$45.00
Start Price
$25.04
Best Price (1Y)
$29.50
Current Price
$10.51
Return
-58.0%
Oruka Therapeutics, Inc.
ORKA
Jan 07, 2026
Signal & Target
BUY
$50.00
Start Price
$26.62
Best Price (1Y)
$109.42
Current Price
$108.12
Return
+306.2%
Denali Therapeutics Inc
DNLI
Jan 07, 2026
Signal & Target
BUY
$25.00
Start Price
$17.21
Best Price (1Y)
$27.30
Current Price
$24.82
Return
+44.2%
Nuvation Bio Inc - Ordinary Shares - Class A
NUVB
Jan 07, 2026
Signal & Target
BUY
$10.00
Start Price
$8.49
Best Price (1Y)
$9.10
Current Price
$6.10
Return
-28.2%
Inventiva - ADR
IVA
Jan 07, 2026
Signal & Target
BUY
$12.00
Start Price
$4.54
Best Price (1Y)
$7.29
Current Price
$4.60
Return
+1.3%
Cogent Biosciences Inc
COGT
Jan 07, 2026
Signal & Target
BUY
$60.00
Start Price
$34.78
Best Price (1Y)
$43.39
Current Price
$37.31
Return
+7.3%
Immunocore Holdings plc - ADR
IMCR
Jan 07, 2026
Signal & Target
BUY
$55.00
Start Price
$32.85
Best Price (1Y)
$36.26
Current Price
$34.20
Return
+4.1%
Schrodinger Inc
SDGR
Jan 07, 2026
Signal & Target
SELL
$18.00
Start Price
$18.79
Best Price (1Y)
$10.95
Current Price
$18.46
Return
+1.8%
Beam Therapeutics Inc
BEAM
Jan 07, 2026
Signal & Target
SELL
$28.00
Start Price
$28.34
Best Price (1Y)
$21.63
Current Price
$26.51
Return
+6.5%
SAB Biotherapeutics Inc
SABS
Jan 07, 2026
Signal & Target
BUY
$7.00
Start Price
$3.62
Best Price (1Y)
$5.15
Current Price
$3.75
Return
+3.6%
Arcellx Inc
ACLX
Jan 07, 2026
Signal & Target
BUY
$100.00
Start Price
$62.06
Best Price (1Y)
$115.13
Current Price
$115.07
Return
+85.4%
AnaptysBio Inc
ANAB
Jan 07, 2026
Signal & Target
BUY
$70.00
Start Price
$43.91
Best Price (1Y)
$72.27
Current Price
$56.02
Return
+27.6%
Scholar Rock Holding Corp
SRRK
Jan 07, 2026
Signal & Target
BUY
$60.00
Start Price
$41.31
Best Price (1Y)
$58.49
Current Price
$53.06
Return
+28.4%
Kodiak Sciences Inc
KOD
Jan 07, 2026
Signal & Target
BUY
$50.00
Start Price
$25.05
Best Price (1Y)
$47.84
Current Price
$39.98
Return
+59.6%
Aligos Therapeutics Inc
ALGS
Jan 07, 2026
Signal & Target
BUY
$20.00
Start Price
$8.76
Best Price (1Y)
$10.49
Current Price
$6.77
Return
-22.7%
Vertex Pharmaceuticals, Inc.
VRTX
Jan 06, 2026
Signal & Target
BUY
$535.00
Start Price
$468.38
Best Price (1Y)
$546.17
Current Price
$516.44
Return
+10.3%
Lilly(Eli) & Co
LLY
Jan 06, 2026
Signal & Target
BUY
$1,250.00
Start Price
$1,064.04
Best Price (1Y)
$1,249.45
Current Price
$1,209.85
Return
+13.7%